RC
SNY icon

RegentAtlantic Capital’s Sanofi SNY Stock Holding History

RegentAtlantic Capital’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,273
Closed -$442K – 428
2017
Q4 		$442K Sell
10,273
-145
-1% -$6.69K 0.04% 294
2017
Q3 		$519K Sell
10,418
-339
-3% -$16.4K 0.04% 275
2017
Q2 		$515K Sell
10,757
-1,640
-13% -$78.4K 0.05% 273
2017
Q1 		$561K Sell
12,397
-3,314
-21% -$141K 0.05% 262
2016
Q4 		$635K Buy
15,711
+7,255
+86% +$286K 0.06% 245
2016
Q3 		$323K Buy
+8,456
New +$339K 0.03% 317
2015
Q1 		– Sell
-1,091
Closed -$49.8K – 852
2014
Q4 		$49.8K Buy
+1,091
New +$52.9K ﹤0.01% 586

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RegentAtlantic Capital's SNY Position: Q1 2018 in Review

RegentAtlantic Capital sold out of Sanofi (SNY) in Q1 2018, closing a stake of 10,273 shares — an estimated $442K sold.

RegentAtlantic Capital first reported a position in SNY in Q4 2014 and held it in 7 quarters. The position peaked at $635K in Q4 2016. 487 funds tracked by Wall St. Rank hold SNY as of Q1 2018.

  • RegentAtlantic Capital reported no remaining Sanofi position as of Q1 2018 after selling out during the quarter.
  • RegentAtlantic Capital sold 10,273 Sanofi shares in Q1 2018, an estimated $442K.
  • RegentAtlantic Capital first reported a position in Sanofi in Q4 2014 and held it in 7 quarters.
  • RegentAtlantic Capital's Sanofi position peaked at $635K in Q4 2016.
  • 487 funds tracked by Wall St. Rank held Sanofi as of Q1 2018.

Based on RegentAtlantic Capital's 13F filing for Q1 2018, filed 23 Apr 2018.